ReviewExperimental biology and medicine (Maywood, N.J.)2022

Preclinical and clinical studies of bintrafusp alfa, a novel bifunctional anti-PD-L1/TGFβRII agent: Current status.

Sofia R Gameiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.